{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:37:25Z","timestamp":1792705045056,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T00:00:00Z","timestamp":1494460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T00:00:00Z","timestamp":1494460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s40262-017-0553-1","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T19:45:53Z","timestamp":1494531953000},"page":"209-219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Safety and Tolerability of Intravenous Valproic Acid in Healthy Subjects: A Phase I Dose-Escalation Trial"],"prefix":"10.1007","volume":"57","clinical-trial-number":[{"clinical-trial-number":"nct01951560","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Patrick E.","family":"Georgoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahagn C.","family":"Nikolian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess","family":"Bonham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjunath P.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Tafatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihab","family":"Halaweish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuanwong","family":"Watcharotone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Parameswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duxin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan B.","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,11]]},"reference":[{"issue":"10","key":"553_CR1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","volume":"16","author":"E Perucca","year":"2002","unstructured":"Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35\u00a0years of clinical experience. CNS Drugs. 2002;16(10):695\u2013714.","journal-title":"CNS Drugs"},{"issue":"Suppl. 1","key":"553_CR2","first-page":"S91","volume":"83","author":"M Gottlicher","year":"2004","unstructured":"Gottlicher M. Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases. Ann Hematol. 2004;83(Suppl. 1):S91\u20132.","journal-title":"Ann Hematol"},{"issue":"6649","key":"553_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/38664","volume":"389","author":"M Grunstein","year":"1997","unstructured":"Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 1997;389(6649):349\u201352.","journal-title":"Nature"},{"issue":"5942","key":"553_CR4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1126\/science.1175371","volume":"325","author":"C Choudhary","year":"2009","unstructured":"Choudhary C, Kumar C, Gnad F, et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009;325(5942):834\u201340.","journal-title":"Science"},{"issue":"1","key":"553_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1172\/JCI69738","volume":"124","author":"AC West","year":"2014","unstructured":"West AC, Johnstone RW. New and emerging HDAC inhibitors for cancer treatment. J Clin Invest. 2014;124(1):30\u20139.","journal-title":"J Clin Invest"},{"issue":"10","key":"553_CR6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd2681","volume":"7","author":"AG Kazantsev","year":"2008","unstructured":"Kazantsev AG, Thompson LM. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov. 2008;7(10):854\u201368.","journal-title":"Nat Rev Drug Discov"},{"issue":"1\u20132","key":"553_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13148-010-0002-6","volume":"1","author":"E Toussirot","year":"2010","unstructured":"Toussirot E, Khan KA, Herbein G. Histone deacetylase inhibitors: a new and promising drug class for the treatment of arthritis? Clin Epigenetics. 2010;1(1\u20132):3\u20136.","journal-title":"Clin Epigenetics"},{"issue":"Suppl. 1","key":"553_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/SHK.0000000000000319","volume":"44","author":"I Halaweish","year":"2015","unstructured":"Halaweish I, Nikolian V, Georgoff P, et al. Creating a \u201cprosurvival phenotype\u201d through histone deacetylase inhibition: past, present, and future. Shock. 2015;44(Suppl. 1):6\u201316.","journal-title":"Shock"},{"issue":"2","key":"553_CR9","first-page":"71","volume":"10","author":"A Boyum","year":"1977","unstructured":"Boyum A. Separation of lymphocytes, lymphocyte subgroups and monocytes: a review. Lymphology. 1977;10(2):71\u20136.","journal-title":"Lymphology"},{"issue":"5","key":"553_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/archsurg.1993.01420170107016","volume":"128","author":"SR Shackford","year":"1993","unstructured":"Shackford SR, Mackersie RC, Holbrook TL, et al. The epidemiology of traumatic death: a population-based analysis. Arch Surg. 1993;128(5):571\u20135.","journal-title":"Arch Surg"},{"issue":"5","key":"553_CR11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jama.2015.12","volume":"313","author":"JB Holcomb","year":"2015","unstructured":"Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471\u201382.","journal-title":"JAMA"},{"issue":"6","key":"553_CR12","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.jemermed.2015.09.013","volume":"49","author":"PT Pons","year":"2015","unstructured":"Pons PT, Jerome J, McMullen J, et al. The Hartford consensus on active shooters: implementing the continuum of prehospital trauma response. J Emerg Med. 2015;49(6):878\u201385.","journal-title":"J Emerg Med"},{"issue":"2","key":"553_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.surg.2009.04.007","volume":"146","author":"HB Alam","year":"2009","unstructured":"Alam HB, Shuja F, Butt MU, et al. Surviving blood loss without blood transfusion in a swine poly-trauma model. Surgery. 2009;146(2):325\u201333.","journal-title":"Surgery"},{"issue":"1","key":"553_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jss.2010.04.013","volume":"163","author":"EY Fukudome","year":"2010","unstructured":"Fukudome EY, Kochanek AR, Li Y, et al. Pharmacologic resuscitation promotes survival and attenuates hemorrhage-induced activation of extracellular signal-regulated kinase 1\/2. J Surg Res. 2010;163(1):118\u201326.","journal-title":"J Surg Res"},{"issue":"2","key":"553_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.surg.2010.05.003","volume":"148","author":"Y Li","year":"2010","unstructured":"Li Y, Liu B, Fukudome EY, et al. Surviving lethal septic shock without fluid resuscitation in a rodent model. Surgery. 2010;148(2):246\u201354.","journal-title":"Surgery"},{"issue":"6","key":"553_CR16","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1097\/TA.0000000000000345","volume":"77","author":"SE Dekker","year":"2014","unstructured":"Dekker SE, Bambakidis T, Sillesen M, et al. Effect of pharmacologic resuscitation on the brain gene expression profiles in a swine model of traumatic brain injury and hemorrhage. J Trauma Acute Care Surg. 2014;77(6):906\u201312 discussion 12.","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"553_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.surg.2013.04.003","volume":"154","author":"T Zhao","year":"2013","unstructured":"Zhao T, Li Y, Liu B, et al. Novel pharmacologic treatment attenuates septic shock and improves long-term survival. Surgery. 2013;154(2):206\u201313.","journal-title":"Surgery"},{"issue":"6","key":"553_CR18","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/TA.0000000000000789","volume":"79","author":"I Halaweish","year":"2015","unstructured":"Halaweish I, Bambakidis T, Chang Z, et al. Addition of low-dose valproic acid to saline resuscitation provides neuroprotection and improves long-term outcomes in a large animal model of combined traumatic brain injury and hemorrhagic shock. J Trauma Acute Care Surg. 2015;79(6):911\u20139.","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"553_CR19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/TA.0000000000000333","volume":"77","author":"CH Jepsen","year":"2014","unstructured":"Jepsen CH, deMoya MA, Perner A, et al. Effect of valproic acid and injury on lesion size and endothelial glycocalyx shedding in a rodent model of isolated traumatic brain injury. J Trauma Acute Care Surg. 2014;77(2):292\u20137.","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"553_CR20","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1097\/TA.0b013e3182782641","volume":"73","author":"G Jin","year":"2012","unstructured":"Jin G, Duggan M, Imam A, et al. Pharmacologic resuscitation for hemorrhagic shock combined with traumatic brain injury. J Trauma Acute Care Surg. 2012;73(6):1461\u201370.","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"553_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2165\/00003088-198005010-00002","volume":"5","author":"R Gugler","year":"1980","unstructured":"Gugler R, von Unruh GE. Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet. 1980;5(1):67\u201383.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"553_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/sj.bjc.6603851","volume":"97","author":"A Atmaca","year":"2007","unstructured":"Atmaca A, Al-Batran SE, Maurer A, et al. Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial. Br J Cancer. 2007;97(2):177\u201382.","journal-title":"Br J Cancer"},{"issue":"15","key":"553_CR23","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1200\/JCO.2006.08.6165","volume":"25","author":"P Munster","year":"2007","unstructured":"Munster P, Marchion D, Bicaku E, et al. Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study. J Clin Oncol. 2007;25(15):1979\u201385.","journal-title":"J Clin Oncol"},{"key":"553_CR24","volume-title":"Pharmacovigilance","author":"E Brown","year":"2006","unstructured":"Brown E. Medical dictionary for regulatory activities (MedDRA\u00ae). In: Mann RD, Andrews EB, editors. Pharmacovigilance. 2nd ed. Chichester: John Wiley & Sons Ltd; 2006.","edition":"2"},{"key":"553_CR25","doi-asserted-by":"crossref","unstructured":"Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972;1(4):233\u20138.","DOI":"10.1093\/ageing\/1.4.233"},{"issue":"3","key":"553_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201d\u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res"},{"issue":"6","key":"553_CR27","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1097\/TA.0000000000001249","volume":"81","author":"P Georgoff","year":"2016","unstructured":"Georgoff P, Halaweish I, Nikolian V, et al. Alterations in the human proteome following administration of valproic acid. J Trauma Acute Care Surg. 2016;81(6):1020\u20137.","journal-title":"J Trauma Acute Care Surg"},{"issue":"7","key":"553_CR28","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1081\/CLT-100102388","volume":"38","author":"HA Spiller","year":"2000","unstructured":"Spiller HA, Krenzelok EP, Klein-Schwartz W, et al. Multicenter case series of valproic acid ingestion: serum concentrations and toxicity. J Toxicol Clin Toxicol. 2000;38(7):755\u201360.","journal-title":"J Toxicol Clin Toxicol"},{"key":"553_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-017-2130-6","author":"GA Higgins","year":"2017","unstructured":"Higgins GA, Georgoff P, Nikolian V. Network reconstruction reveals that valproic acid activates neurogenic transcriptional progamsin adult brain following traumatic injury. 2017;. doi:10.1007\/s11095-017-2130-6 [Epub ahead of print].","journal-title":"Network reconstruction reveals that valproic acid activates neurogenic transcriptional progamsin adult brain following traumatic injury."},{"key":"553_CR30","volume-title":"Pharmacologic resuscitation decreases blood-brain barrier permeability in a porcine model of traumatic brain injury and hemorrhagic shock","author":"V Nikolian","year":"2016","unstructured":"Nikolian V, Dekker SE, Bamdakidis T, et al. Pharmacologic resuscitation decreases blood-brain barrier permeability in a porcine model of traumatic brain injury and hemorrhagic shock. Washington, DC: American College of Surgeons; 2016."}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-017-0553-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-017-0553-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-017-0553-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T17:25:46Z","timestamp":1628616346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-017-0553-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,11]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["553"],"URL":"https:\/\/doi.org\/10.1007\/s40262-017-0553-1","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,11]]},"assertion":[{"value":"11 May 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This work was funded by the Department of Defense Office of Naval Research (N000141310071) and the National Institutes of Health Center for Advancing Translational Sciences (UL1TR000433). The Michigan Institute for Clinical Health Research provided guidance, data design, and clinical research space. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, or the US Department of Defense.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Patrick E. Geogoff, Vahagn C. Nikolian, Tess Bonham, Manjunath P. Pai, Celia Tafatia, Ihab Halaweish, Kathleen To, Kuanwong Watcharotone, Aishwarya Parameswaran, Ruijuan Lao, Duxin Sun, and Hasan B. Alam have no conflicts of interest directly relevant to the contents of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}